An expert advisory panel has recommended that the Food and Drug Administration approve Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for… Read more »
Tag: Aimmune Therapeutics
Patch Progress, Peanut OIT in Adults Data Presented at EAACI Meeting
We’re learning more about the two therapies to treat peanut allergies that could soon be available in allergist’s offices in… Read more »
Peanut OIT Therapy Sees Success, Boosting Hope for FDA Approval
An FDA-approved treatment for food allergy is closer to reality after Aimmune Therapeutics announced that its large, Phase 3 trial… Read more »
OIT Therapy Gets Ready for Prime Time
Peanut oral immunotherapy in a capsule is moving closer to regulatory approval in the United States. The therapy brings hope – not for a cure – but of lives made less vulnerable.
FARE’s Dr. Baker: Finding Peace of Mind While We Search for a Cure
Why FARE (Food Allergy Research & Education) thinks desensitization is a vital food allergy therapy on the path toward finding tolerance.
Standarized OIT Takes Steps Forward
A pharmaceutical approach to oral immunotherapy is a step closer to approval by the Food and Drug Administration. The treatment,… Read more »